Probiotics and Allergic Rhinitis: A Simon Two-Stage Design to Determine Effectiveness

Area of Science:

• Integrative medicine
• Allergy research
• Microbiome science

Background:

• Allergic rhinitis (AR) affects 10-30% globally, posing significant health and economic burdens.
• Probiotics are investigated for immune conditions like AR, but clinical evidence is hampered by trial design limitations.
• Progressive clinical trial designs offer a pathway to gather robust data for regulatory approval.

Purpose of the Study:

• To evaluate the efficacy of a multispecies probiotic supplement in patients with allergic rhinitis.
• To demonstrate the utility of a Simon Two-Stage Design for preliminary probiotic research in AR.
• To generate empirical data for designing future, larger-scale clinical trials.

Main Methods:

• A Phase II study employing a Simon Two-Stage Design.
• 8-week intervention with a twice-daily multispecies probiotic.
• Assessment of symptom improvement using mini-Rhinoconjunctivitis Quality of Life Questionnaire, symptom/medication diaries, and nasal rhinomanometry.

Main Results:

• The study provides preliminary data on the response rate to a novel probiotic in AR patients.
• Mini-Rhinoconjunctivitis Quality of Life Questionnaire scores indicated symptom improvement.
• Secondary outcomes assessed changes in symptom frequency, medication use, and nasal congestion.

Conclusions:

• The Simon Two-Stage Design is valuable for complementary and alternative medicine research, particularly for probiotics.
• The multispecies probiotic shows potential as a therapeutic intervention for allergic rhinitis.
• Further placebo-controlled studies are warranted to confirm these findings.